Neuropharmacological mechanisms of drug reward: Beyond dopamine in the nucleus accumbens

Critical Reviews in Neurobiology

Volumn 12, Issue 1-2, 1998, Pages 37-67

  Bardo, Michael T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Amphetamine; Amygdala; Cocaine; Opiates; Ventral pallidum; Ventral tegmental area

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; AMPHETAMINE; COCAINE; DOPAMINE; GLUTAMIC ACID; NEUROTRANSMITTER; OPIATE; PEPTIDE; SEROTONIN;

AMYGDALOID NUCLEUS; DRUG ABUSE; GLOBUS PALLIDUS; HIPPOCAMPUS; HYPOTHALAMUS; MESOLIMBIC DOPAMINERGIC SYSTEM; MICROINJECTION; NERVE CELL NETWORK; NEUROPHARMACOLOGY; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PREFRONTAL CORTEX; REVIEW; REWARD; TEGMENTUM; VENTRAL TEGMENTUM;

EID: 0031978679     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevneurobiol.v12.i1-2.30     Document Type: Review

References (220)

1. Bozarth, M. A., Ed., Methods of Assessing the Reinforcing Properties of Abused Drugs, Springer-Verlag, New York, 1987.
2. Crabbe, J. C., Belknap, J. K., and Buck, K. J., Genetic animal models of alcohol and drug abuse, Science, 264, 1715, 1994.
3. Self, D. W. and Nestler, E. J., Molecular mechanisms of drug reinforcement and addiction, Ann. Rev. Neurosci., 18, 463, 1995.
4. Yokel, R. A., Intravenous self-administration: response rates, the effects of pharmacological challenges, and drug preference, in Methods of Assessing the Reinforcing Properties of Abused Drugs, Bozarth, M. A., Ed., Springer-Verlag, New York, 1987, 1.
5. Goldberg, S. R. and Kelleher, R. T., Behavior controlled by scheduled injections of cocaine in squirrel monkeys, J. Exp. Anal. Behav., 25, 93, 1976.
6. Richardson, N. R. and Roberts, D. C. S., Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy, J. Neurosci. Meth., 66, 1, 1996.
7. Carr, G. D., Fibiger, H. C., and Phillips, A. G., Conditioned place preference as a measure of drug reward, in The Neuropharmacological Basis of Reward, Leibman, J. M. and Cooper, S. J., Eds., Oxford, New York, 1989, 264.
8. Bardo, M. T., Rowlett, J. K., and Harris, M. J., Conditioned place preference using opiate and stimulant drugs: a meta-analysis, Neurosci. Biobehav. Rev., 19, 39, 1995.
9. Bardo, M. T., Neisewander, J. L., and Pierce, R. C., Novelty-induced place preference behavior in rats: effects of opiate and dopaminergic drugs, Pharmacol. Biochem. Behav., 32, 683, 1989.
10. Parker, L. A., Place conditioning in a three- or four-choice apparatus: role of stimulus novelty in drug-induced place conditioning, Behav. Neurosci., 106, 294, 1992.
11. Schulteis, G. and Koob, G. F., Reinforcement processes in opiate addiction: a homeostatic model, Neurochem. Res., 21, 1437, 1996.
12. Nader, K., Bechara, A., Roberts, D. C. S., and van der Kooy, D., Neuroleptics block high- but not low-dose heroin place preferences: further evidence for a two-system model of motivation, Behav. Neurosci., 108, 1128, 1994.
13. Caine, S. B., Heinrichs, S. C., Coffin, V. L., and Koob, G. F., Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat, Brain Res., 692, 47, 1995.
14. Zahm, D. S. and Brog, J. S., On the significance of subterritories in the "accumbens" part of the rat ventral striatum, Neuroscience, 50, 751, 1992.
15. Graybiel, A. M. and Moratalla, R., Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments, Proc. Natl. Acad. Sci. U.S.A., 86, 9020, 1989.
16. Roberts, D. C. S. and Vickers, G., Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioral screen for antipsychotic activity, Psychopharmacology, 82, 135, 1984.
17. 2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys, Pharmacol. Biochem. Behav., 24, 531, 1986.
18. Morency, M. A. and Beninger, R. J., Dopaminergic substrates of cocaine-induced place conditioning, Brain Res., 399, 33, 1986.
19. Spyraki, C., Fibiger, H. C., and Phillips, A. G., Dopaminergic substrates of amphetamine-induced place preference conditioning, Brain Res., 253, 185, 1982.
20. Vanover, K. E. and Woolverton, W. L., Behavioral effects of the dopamine autoreceptor agonist PD 128483 alone and in combination with cocaine, J. Pharmacol. Exp. Ther., 270, 1049, 1994.
21. Richardson, N. R., Piercey, M. F., Svensson, K., Collins, R. J., Myers, J. E., and Roberts, D. C. S., Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist, (+)-AJ 76, Brain Res., 619, 15, 1993.
22. Vanover, K. E., Piercey, M. F., and Woolverton, W. L., Evaluation of the reinforcing and discriminative stimulus effects of cocaine in combination with (+)-AJ 76 or clozapine, J. Pharmacol. Exp. Ther., 266, 780, 1993.
23. Caine, S. B. and Koob, G. F., Modulation of cocaine self-administration in the rat through D-3 dopamine receptors, Science, 260, 1814, 1993.
24. De Fonseca, F. R., Rubio, P., Martin-Calderon, J. L., Caine, S. B., Koob, G. F., and Navarro, M., The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference, Eur. J. Pharmacol., 274, 47, 1995.
25. Caine, S. B. and Koob, G. F., Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat, Behav. Pharmacol., 6, 333, 1995.
26. 3 preferring compounds on conditioned place preference and intracranial self-stimulation in the rat, J. Neural Trans., 101, 27, 1995.
27. Loh, E. A., Fitch, T., Vickers, G., and Roberts, D. C. S., Clozapine increases breaking points on a progressive-ratio schedule reinforced by intravenous cocaine, Pharmacol. Biochem. Behav., 42, 559, 1992.
28. Woolverton, W. L., Goldberg, L. I., and Ginos, J. Z., Intravenous self-administration of dopamine receptor agonists by rhesus monkeys, J. Pharmacol. Exp. Ther., 230, 678, 1984.
29. 2 receptor antagonists on the establishment of agonist-induced place conditioning in rats, Pharmacol. Biochem. Behav., 33, 273, 1989.
30. 1 agonists SKF 82958 and SKF 77434 are self-administered by rats, Brain Res., 582, 349, 1992.
31. 1 dopamine agonist SKF 81297 in rhesus monkeys, Psychopharmacology, 113, 51, 1993.
32. 2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat, J. Pharmacol. Exp. Ther., 270, 209, 1994.
33. Hubner, C. B. and Moreton, J. E., Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat, Psychopharmacology, 105, 151, 1991.
34. Cervo, L. and Samanin, R., Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioned place preference, Brain Res., 673, 242, 1995.
35. 2 dopamine antagonist on behavior maintained by cocaine or food, Pharmacol. Biochem. Behav., 32, 691, 1989.
36. Di Chiara, G., The role of dopamine in drug abuse viewed from the perspective of its role in motivation, Drug Alcohol Depend., 38, 95, 1995.
37. Wise, R. A. and Hoffman, D. C., Localization of drug reward mechanisms by intracranial injections, Synapse, 10, 247, 1992.
38. Bozarth, M. A. and Wise, R. A., Heroin reward is dependent on a dopaminergic substrate, Life Sci., 29, 1881, 1981.
39. Ettenberg, A., Pettit, H. O., Bloom, F. E., and Koob, G. F., Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems, Psychopharmacology, 78, 204, 1982.
40. Mackey, W. B. and van der Kooy, D., Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning, Pharmacol. Biochem. Behav., 22, 101, 1985.
41. 2 receptor antagonists, Eur. J. Pharmacol., 151, 233, 1988.
42. Acquas, E., Carboni, E., Leone, P., and Di Chiara, G., SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology, 99, 151, 1989.
43. 1-dopamine receptors in the motivational properties of μ,- and K-opioid agonists, Brain Res., 436, 169, 1987.
44. Weiss, F., Mitchiner, M., Bloom, F. E., and Koob, G. F., Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methyseride, Psychopharmacology, 101, 178, 1990.
45. Risinger, F. O., Dickinson, S. D., and Cunningham, C. L., Haloperidol reduces ethanol-induced motor activity stimulation but not conditioned place preference, Psychopharmacology, 107, 453, 1992.
46. Davis, W. M. and Smith, S. G., Catecholamine mechanisms of reinforcement: direct assessment by drug self-administration, Life Sci., 20, 483, 1977.
47. Woolverton, W. L., Wessinger, W. D., and Balster, R. L., Reinforcing properties of clonidine in rhesus monkeys, Psychopharmacology, 77, 17, 1982.
48. Asin, K. E. and Wirtshafter, D., Clonidine produces a conditioned place preference in rats, Psychopharmacology, 85, 383, 1985.
49. 2-adrenoceptors outside the locus coeruleus, Eur. J. Pharmacol., 238, 201, 1993.
50. Woolverton, W. L., Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys, Pharmacol. Biochem. Behav., 26, 835, 1987.
51. Carroll, M. E., Lac, S. T., Asencio, M., and Kragh, R., Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan, Psychopharmacology, 100, 293, 1990.
52. Smith, F. L., Yu, D. S. L., Smith, D. G., Leccese, A. P., and Lyness, W. H., Dietary tryptophan supplements attenuate amphetamine self-administration in the rat, Pharmacol. Biochem. Behav., 25, 849, 1986.
53. McGregor, A., Lacosta, S., and Roberts, D. C. S., L-Tryptophan decreases the breaking point under a progressive ratio schedule of intravenous cocaine reinforcement in the rat, Pharmacol. Biochem. Behav., 44, 651, 1993.
54. Leccese, A. P. and Lyness, W. H., The effects of putative 5-hydroxytryptamine receptor active agents on amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions, Brain Res., 303, 153, 1984.
55. Porrino, L. J., Ritz, M. C., Goodman, N. L., Sharpe, L. G., Kuhar, M. J., and Goldberg, S. R., Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats, Life Sci., 45, 1529, 1989.
56. Peltier, R. and Schenk, S., Effects of serotonergic manipulations on cocaine self-administration in rats, Psychopharmacology, 110, 390, 1993.
57. Lyness, W. H., and Smith, F. L., Influence of dopaminergic and serotonergic neurons on intravenous ethanol self-administration in the rat, Pharmacol. Biochem. Behav., 42, 187, 1992.
58. Higgins, G. A., Wang, Y., and Sellers, E. M., Preliminary findings with the indirect 5-HT agonist dexfenfluramine on heroin discrimination and self-administration in rats, Pharmacol. Biochem. Behav., 45, 963, 1993.
59. 3 receptor antagonists and the indirect 5-HT agonist, dexfenfluramine, on heroin self-administration in rats, Psychopharmacology, 114, 611, 1994.
60. Roberts, D. C. S., Loh, E. A., Baker, G. B., and Vickers, G., Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food, Pharmacol. Biochem. Behav., 49, 177, 1994.
61. Papp, M. and Willner, P., 8-OH-DPAT-induced place preference and place aversion: effects of PCPA and dopamine antagonists, Psychopharmacology, 103, 99, 1991.
62. 3 antagonists ICS 205-930 and MDL 72222, Pharmacol. Biochem. Behav., 49, 67, 1994.
63. Lacosta, S. and Roberts, D. C. S., MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine, Pharmacol. Biochem. Behav., 44, 161, 1993.
64. Peltier, R. L., Emmett-Oglesby, M. W., Thomas, W. H., and Schenk, S., Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine, Pharmacol. Biochem. Behav., 48, 473, 1994.
65. 3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats, Pharmacol. Biochem. Behav., 55, 33, 1996.
66. Hernandez, L., Lee, F., and Hoebel, B. G., Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: increase in extracellular dopamine and serotonin, Brain Res. Bull., 19, 623, 1987.
67. 3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward, Psychopharmacology, 97, 175, 1989.
68. 3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats, J. Pharmacol. Exp. Ther., 264, 1440, 1993.
69. 3 receptor antagonists, MDL 72222 and ondansetron on morphine place conditioning, Psychopharmacology, 106, 315, 1992.
70. 3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats, Alcohol Alcohol., 26, 107, 1991.
71. 3 antagonist ICS 205-930, Alcohol, 10, 191, 1993.
72. 3 antagonist ondansetron in alcohol abuse and dependence, Alcohol Clin. Exp. Res., 18, 879, 1994.
73. 3 receptors in drug dependence, Drug Alcohol Depend., 38, 155, 1995.
74. Borg, P. J. and Taylor, D. A., Voluntary oral morphine self-administration in rats: effect of haloperidol or ondansetron, Pharmacol. Biochem. Behav., 47, 633, 1994.
75. Nomikos, G. G. and Spyraki, C., Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats, Pharmacol. Biochem. Behav., 30, 853, 1988.
76. Myers, R. D., Lankford, M. F., and Bjork, A., Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cynanamide, Pharmacol. Biochem. Behav., 43, 661, 1992.
77. 2 receptor antagonist, ritanserin, to alter preference for alcohol in drinking rats, Pharmacol. Biochem. Behav., 45, 233, 1993.
78. Fudala, P. J., Teoh, K. W., and Iwamoto, E. T., Pharmacologic characterization of nicotine-induced conditioned place preference, Pharmacol. Biochem. Behav., 22, 237, 1985.
79. Calcagnetti, D. J. and Schechter, M. D., Nicotine place preference using the biased method of conditioning, Prog. Neuro-Psychopharmacol. Biol. Psychiat., 18, 925, 1994.
80. Clarke, P. B. S. and Fibiger, H. C., Apparent absence of nicotine-induced conditioned place preference in rats, Psychopharmacology, 92, 84, 1987.
81. Donny, E. C., Caggiula, A. R., Knopf, S., and Brown, C., Nicotine self-administration, Psychopharmacology, 122, 390, 1995.
82. Goldberg, S. R., Spealman, R. D., and Goldberg, D. M., Persistent behavior at high rates maintained by intravenous self-administration of nicotine, Science, 214, 573, 1981.
83. Trujillo, K. A. and Akil, H., Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence, Drug Alcohol Depend., 38, 139, 1995.
84. Koek, W., Woods, J. H., and Winger, G. D., MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys, J. Pharmacol. Exp. Ther., 245, 969, 1988.
85. Young, A. M. and Woods, J. H., Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories, J. Pharmacol. Exp. Ther., 218, 720, 1981.
86. Hoffman, D. C., The noncompetitive NMDA antagonist MK-801 fails to block amphetamine- induced place conditioning in rats, Pharmacol. Biochem. Behav., 47, 907, 1994.
87. Layer, R. T., Kaddis, F. G., and Wallace, L. J., The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats, Pharmacol. Biochem. Behav., 44, 245, 1993.
88. Carroll, M. E., Carmona, G. N., and Rodefer, J. S., Phencyclidine (PCP) self-administration and withdrawal in rhesus monkeys: effects of buprenorphine and dizocilpine (MK-801) pretreatment, Pharmacol. Biochem. Behav., 48, 723, 1994.
89. Schenk, S., Valadez, A., McNamara, C., House, D. T., Higley, D., Bankson, M. G., Gibbs, S., and Horger, B. A., Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors, Psychopharmacology, 111, 332, 1993.
90. Bespalov, A., Dumpis, M., Piotrovsky, L., and Zvartau, E., Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine, Eur. J. Pharmacol., 264, 233, 1994.
91. Kim, H. S., Jang, C. G., and Park, W. K., Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice, Pharmacol. Biochem. Behav., 55, 11, 1996.
92. Cooper, J. R., Bloom, F. E., and Roth, R. H., The Biochemical Basis of Neuropharmacology, Oxford University Press, New York, 1996.
93. Boyle, A. E., Segal, R., Smith, B. R., and Amit, Z., Bidirectional effects of GABAergic agonists and antagonists on maintenance of voluntary ethanol intake in rats, Pharmacol. Biochem. Behav., 46, 179, 1993.
94. Smith, B. R., Robidoux, R., and Amit, Z., Gabaergic involvement in the acquisition of voluntary ethanol intake in laboratory rats, Alcohol Alcohol, 27, 227, 1992.
95. Boismare, F., Daoust, M., Moore, N., Saligaut, C., Lhuintre, J. P., Chretien, P., and Durlach, J., A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Pharmacol. Biochem. Behav., 21, 787, 1984.
96. Daoust, M., Saligaut, C., Lhuintre, J. P., Moore, N., Flipo, J. L., and Boismare, F., Gaba transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats, Alcohol, 4, 469, 1987.
97. Risinger, F. O., Malott, D. H., Riley, A. L., and Cunningham, C. L., Effect of Ro 15-4513 on ethanol-induced conditioned place preference, Pharmacol. Biochem. Behav., 43, 97, 1992.
98. June, H. L., Hughes, R. W., Spurlock, H. L., and Lewis, M. J., Ethanol self-administration in freely feeding and drinking rats: effects of Ro 15-4513 alone, and in combination with Ro 15-1788 (flumazenil), Psychopharmacology, 115, 332, 1994.
99. Samson, H. H., Haraguchi, M., Tolliver, G. A., and Sadeghi, K. G., Antagonism of ethanol-reinforced behavior by the benzodiazepine inverse agonists Ro 15-4513 and FG 7142: relation to sucrose reinforcement, Pharmacol. Biochem. Behav., 33, 601, 1989.
100. Woods, J. H., Katz, J. L., and Winger, G., Abuse liability of benzodiazepines, Pharmacol. Rev., 39, 251, 1987.
101. Di Scala, G., Oberling, P., Rocha, B., and Sandner, G., Conditioned place preference induced by Ro 16-6028, a benzodiazepine receptor partial agonist, Pharmacol. Biochem. Behav., 41, 859, 1992.
102. Pettit, H. O., Batsell, W. R., and Mueller, K., Triazolam attenuates amphetamine but not morphine conditioned place preferences, Psychopharmacology, 98, 483, 1989.
103. Di Scala, G., Martin-Iversen, M. T., Phillips, A. G., and Fibiger, H. C., The effects of progabide (SL 76002) on locomotor activity and conditioned place preference induced by d-amphetamine, Eur. J. Pharmacol., 107, 271, 1985.
104. Goeders, N. E., McNulty, M. A., and Guerin, G. F., Effects of alprazolam on intravenous cocaine self-administration in rats, Pharmacol. Biochem. Behav., 44, 471, 1993.
105. Goeders, N. E., McNulty, M. A., Mirkis, S., and McAllister, K. H., Chlordiazepoxide alters intravenous cocaine self-administration in rats, Pharmacol. Biochem. Behav., 33, 859, 1989.
106. Koob, G. F., Pettit, H. O., Ettenberg, A., and Bloom, F. E., Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat, J. Pharmacol. Exp. Ther., 229, 481, 1984.
107. Herling, S., Downs, D. A., and Woods, J. H., Cocaine, d-amphetamine, and pentobarbital effects on responding maintained by food or cocaine in rhesus monkeys, Psychopharmacology, 64, 261, 1979.
108. Winger, G., Skjoldager, P., and Woods, J. H., Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys, J. Pharmacol. Exp. Ther., 261, 311, 1992.
109. Mello, N. K., Mendelson, J. H., Bree, M. P., and Lukas, S. E., Buprenorphine suppresses cocaine self-administration by rhesus monkeys, Science, 245, 859, 1989.
110. Mello, N. K., Lukas, S. E., Kamien, J. B., Mendelson, J. H., Drieze, J., and Cone, E. J., The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys, J. Pharmacol. Exp. Ther., 260, 1185, 1992.
111. Brown, E. E., Finlay, J. M., Wong, J. T. F., Damsa, G., and Fibiger, H. C., Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse, J. Pharmacol. Exp. Ther., 256, 119, 1991.
112. Masukawa, Y., Suzuki, T., and Misawa, M., Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines, Psychopharmacology, 111, 139, 1993.
113. Carroll, M. E., Lac, S. T., Walker, M. J., Kragh, R., and Newman, T., Effects of naltrexone on intravenous cocaine self-administration in rats during food satiation and deprivation, J. Pharmacol. Exp. Ther., 238, 1, 1986.
114. Corrigall, W. A. and Coen, K. M., Opiate antagonists reduce cocaine but not nicotine self-administration, Psychopharmacology, 104, 167, 1991.
115. De Vry, J., Donselaar, I., and van Ree, J. M., Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol, J. Pharmacol. Exp. Ther., 251, 735, 1989.
116. Ramsey, N. F. and van Ree, J. M., Intracerebro-ventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats, Pharmacol. Biochem. Behav., 40, 807, 1991.
117. Houdi, A. A., Bardo, M. T., and Van Loon, G. R., Opioid mediation of cocaine-induced hyperactivity and reinforcement, Brain Res., 497, 195, 1989.
118. Trujillo, K. A., Belluzzi, J. D., and Stein, L., Naloxone blockade of amphetamine place preference conditioning, Psychopharmacology, 104, 265, 1991.
119. Altschuler, H. L., Phillips, P. E., and Feinhandler, D. A., Alteration of ethanol self-administration by naltrexone, Life Sci., 26, 679, 1980.
120. Samson, H. H. and Doyle, T. F., Oral ethanol self-administration in the rat: effect of naloxone, Pharmacol. Biochem. Behav., 22, 91, 1985.
121. Mucha, R. F. and Herz, A., Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning, Psychopharmacology, 86, 274, 1985.
122. Shippenberg, T. S., Bals-Kubik, R., and Herz, A., Motivational properties of opioids: evidence that an activation of δ-receptors mediates reinforcement processes, Brain Res., 436, 234, 1987.
123. Woods, J. H., Smith, C. B., Medzihradsky, F., and Swain, H. H., Preclinical testing of new analgesic drugs, in Mechanisms of Pain and Analgesic Compounds, Beers, R. F. and Bassett, E. G., Eds., Raven Press, New York, 1979, 429.
124. Negus, S. S., Henriksen, S. J., Mattox, A., Pasternak, G. W., Portoghese, P. S., Takemori, A. E., Weinger, M. B., and Koob, G. F., Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats, J. Pharmacol. Exp. Ther., 265, 1245, 1993.
125. Menkens, K., Bilsky, E. J., Wild, K. D., Portoghese, P. S., Reid, L. D., and Porreca, F., Cocaine place preference is blocked by the δ-opioid receptor antagonist, naltrindole, Eur. J. Pharmacol., 219, 345, 1992.
126. 6-SP6-11 in the rat, Psychopharmacology, 100, 308, 1990.
127. Boix, F., Sandor, P., Nogueira, P. J. C., Huston, J. P., and Schwarting, R. K. W., Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region, Neuroscience, 64, 1045, 1995.
128. Holzhauer-Oitzl, M. S., Boucke, K., and Huston, J. P., Reinforcing properties of substance P in the lateral hypothalamus revealed by conditioned place preference, Pharmacol. Biochem. Behav., 28, 511, 1987.
129. Glimcher, P. W., Margolin, D. M., Giovino, A. A., and Hoebel, B. G., Neurotensin: a new "reward peptide", Brain Res., 291, 119, 1984.
130. B receptor antagonists, Brain Res., 572, 208, 1992.
131. A receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol, Brain Res., 640, 246, 1994.
132. Pennartz, C. M. A., Groenewegen, H. J., and Lopes da Silva, F. H., The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioral, electrophysiological and anatomical data, Prog. Neurobiol., 42, 719, 1994.
133. Carr, G. D. and White, N. M., Anatomical disassociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study, Psychopharmacology, 89, 340, 1986.
134. Hoebel, B. G., Monaco, A. P., Hernandez, L., Aulisi, E. F., Stanley, B. G., and Lenard, L., Self-injection of amphetamine directly into the brain, Psychopharmacology, 81, 158, 1983.
135. Roberts, D. C. S., Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxydopamine lesions of the nucleus accumbens, Pharmacol. Biochem. Behav., 32, 43, 1989.
136. Phillips, G. D., Robbins, T. W., and Everitt, B. J., Bilateral intra-accumbens self- administration of d-amphetamine: antagonism with intra-accumbens SCH-23390 and sulpiride, Psychopharmacology, 114, 477, 1994.
137. Hiroi, N. and White, N. M., The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas, Brain Res., 552, 141, 1991.
138. White, N. M., Packard, M. G., and Hiroi, N., Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens, Psychopharmacology, 103, 271, 1991.
139. Roberts, D. C. S., Corcoran, M. E., and Fibiger, H. C., On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine, Pharmacol. Biochem. Behav., 6, 616, 1977.
140. Roberts, D. C. S., Koob, G. F., Klonoff, P., and Fibiger, H. C., Extinction and recovery of cocaine self administration following 6-OHDA lesions of the nucleus accumbens, Pharmacol. Biochem. Behav., 12, 781, 1980.
141. 1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat, Pharmacol. Biochem. Behav., 45, 239, 1993.
142. Phillips, G. D., Howes, S. R., Whitelaw, R. B., Robbins, T. W., and Everitt, B. J., Isolation rearing impairs the reinforcing efficacy of intravenous cocaine or intra-accumbens d-amphetamine: impaired response to intra-accumbens D1 and D2/D3 dopamine receptor antagonists, Psychopharmacology, 115, 419, 1994.
143. o proteins in nucleus accumbens reduces both cocaine and heroin reinforcement, J. Neurosci., 14, 6239, 1994.
144. Zito, K. A., Vickers, G., and Roberts, D. C. S., Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens, Pharmacol. Biochem. Behav., 23, 1029, 1985.
145. Baker, D. A., Khroyan, T. V., O'Dell, L. E., Fuchs, R. A., and Neisewander, J. L., Differential effects of intra-accumbens sulpiride on cocaine-induced locomotion and conditioned place preference, J. Pharmacol. Exp. Ther., 279, 392, 1996.
146. Kaddis, F. G., Uretsky, N. J., and Wallace, L. J., DNQX in the nucleus accumbens inhibits cocaine-induced conditioned place preference, Brain Res., 697, 76, 1995.
147. Spyraki, C., Fibiger, H. C., and Phillips, A. G., Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions, Brain Res., 253, 195, 1982.
148. Goeders, N. E. and Smith, J. E., Cortical dopaminergic involvement in cocaine reinforcement, Science, 221, 773, 1983.
149. Hemby, S. E., Jones, G. H., Justice, J. B., and Neill, D. B., Conditioned locomotor activity but not conditioned place preference following intra-accumbens infusions of cocaine, Psychopharmacology, 106, 330, 1992.
150. Corrigall, W. A., Coen, K. M., and Adamson, K. L., Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area, Brain Res., 653, 278, 1994.
151. Layer, R. T., Uretsky, N. J., and Wallace, L. J., Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned, place preference, Brain Res., 617, 267, 1993.
152. Pulvirenti, L., Maldonado-Lopez, R., and Koob, G. F., NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat, Brain Res., 594, 327, 1992.
153. Olds, M. E., Reinforcing effects of morphine in the nucleus accumbens, Brain Res., 237, 429, 1982.
154. van der Kooy, D., Mucha, R. F., O'Shaughnessy, M., and Bucenieks, P., Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference, Brain Res., 243, 107, 1982.
155. Corrigall, W. A. and Vaccarino, F. J., Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration, Pharmacol. Biochem. Behav., 30, 443, 1988.
156. Vaccarino, F. J., Bloom, F. E., and Koob, G. F., Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat, Psychopharmacology, 86, 37, 1985.
157. Goeders, N. E., Lane, J. D., and Smith J. E., Self-administration of methionine-enkephalin into the nucleus accumbens, Pharmacol. Biochem. Behav., 20, 451, 1984.
158. Bals-Kubik, R., Ableitner, A., Herz, A., and Shippenberg, T. S., Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats, J. Pharmacol. Exp. Ther., 264, 489, 1993.
159. Smith, J. E., Guerin, G. F., Co, C., Barr, T. S., and Lane, J. D., Effects of 6-OHDA lesions of the central medial nucleus accumbens on rat intravenous morphine self-administration, Pharmacol. Biochem. Behav., 23, 243, 1985.
160. Spyraki, C., Fibiger, H. C., and Phillips, A. G., Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system, Psychopharmacology, 79, 278, 1983.
161. Dworkin, S. I., Guerin, G. F., Co, C., Goeders, N. E., and Smith, J. E., Lack of an effect of 6-hydroxydopamine lesions of the nucleus accumbens on intravenous morphine self-administration, Pharmacol. Biochem. Behav., 30, 1051, 1988.
162. Pettit, H. O., Ettenberg, A., Bloom, F. E., and Koob, G. F., Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration, Psychopharmacology, 84, 167, 1984.
163. Gerrits, M., Ramsey, N. F., Wolterink, G., and van Ree, J. M., Lack of evidence for an involvement of nucleus accumbens dopamine D1 receptors in the initiation of heroin self-administration in the rat, Psychopharmacology, 114, 486, 1994.
164. van Ree, J. M. and Ramsey, N. F., The dopamine hypothesis of opiate reward challenged, Eur. J. Pharmacol., 134, 239, 1987.
165. Smith, J. E., Shultz, K., Co, C., Goeders, N. E., and Dworkin, S. I., Effects of 5,7-dihydroxytryptamine lesions of the nucleus accumbens on rat intravenous morphine self-administration, Pharmacol. Biochem. Behav., 26, 607, 1987.
166. Dworkin, S. I., Guerin, G. F., Goeders, N. E., and Smith, J. E., Kainic acid lesions of the nucleus accumbens selectively attenuate morphine self-administration, Pharmacol. Biochem. Behav., 29, 175, 1988.
167. Spyraki, C. and Fibiger, H. C., A role for the mesolimbic dopamine system in the reinforcing properties of diazepam, Psychopharmacology, 94, 133, 1988.
168. Rassnick, S., Stinus, L., and Koob, G. F., The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat, Brain Res., 623, 16, 1993.
169. Rassnick, S., Pulvirenti, L., and Koob, G. F., Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens, Psychopharmacology, 109, 92, 1992.
170. Hansen, S., Fahlke, C., Hard, E., and Thomasson, R., Effects of ibotenic acid lesions of the ventral striatum and the medial prefrontal cortex on ethanol consumption in the rat, Alcohol, 12, 397, 1995.
171. Phillips, A. G., Broekkamp, C. L., and Fibiger, H. C., Strategies for studying the neurochemical substrates of drug reinforcement in rodents, Prog. Neuropsychopharmacol. Biol. Psychiat., 7, 585, 1983.
172. Goeders, N. E., Dworkin, S. I., and Smith, J. E., Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex, Pharmacol. Biochem. Behav., 24, 1429, 1986.
173. Goeders, N. E. and Smith, J. E., Reinforcing properties of cocaine in the medial prefrontal cortex: primary action on presynaptic dopaminergic terminals, Pharmacol. Biochem. Behav., 25, 191, 1986.
174. Isaac, W. L., Nonneman, A. J., Neisewander, J. L., Landers, T., and
175. Schenk, S., Horger, B. A., Peltier, R., and Shelton, K., Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats, Brain Res., 543, 227, 1991.
176. McGregor, A., Baker, G., and Roberts, D. C. S., Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement, Pharmacol. Biochem. Behav., 53, 5, 1996.
177. Leccese, A. P. and Lyness, W. H., Lesions of dopamine neurons in the medial prefrontal cortex: effects on self-administration of amphetamine and dopamine synthesis in the brain of the rat, Neuropharmacology, 26, 1303, 1987.
178. Corrigall, W. A., Heroin self-administration: effects of antagonist treatment in lateral hypothalamus, Pharmacol. Biochem. Behav., 27, 693, 1987.
179. Kalivas, P. W., Neurotransmitter regulation of dopamine neurons in the ventral tegmental area, Brain Res. Rev., 18, 75, 1993.
180. Yeomans, J. S., Kofman, O., and McFarlane, V., Cholinergic involvement in lateral hypothalamic rewarding brain stimulation, Brain Res., 329, 19, 1985.
181. Phillips, A. G. and LePiane, F. G., Reinforcing effects of morphine microinjection into the ventral tegmental area, Pharmacol. Biochem. Behav., 12, 965, 1980.
182. Self, D. W. and Stein, L., Pertussis toxin attenuates intracranial morphine self-administration, Pharmacol. Biochem. Behav., 46, 689, 1993.
183. Welzl, H., Kühn, G., and Huston, J. P., Self-administration of small amounts of morphine through glass micropipettes into the ventral tegmental area of the rat, Neuropharmacology, 28, 1017, 1989.
184. Devine, D. P. and Wise, R. A., Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats, J. Neurosci., 14, 1978, 1994.
185. Baumeister, A. A., Hurry, M., Curtis, W., Chaney, T. M., Wolf, E., and Leoni, R. R., The antinociceptive and motivational effects of intranigral injection of opioid agonists, Neuropharmacology, 32, 1299, 1993.
186. Glimcher, P. W., Giovino, A. A., and Hoebel, B. G., Neurotensin self-injection in the ventral tegmental area, Brain Res., 403, 147, 1987.
187. Pettit, H. O. and Mueller, K., Infusions of cholecystokinin octapeptide into the ventral tegmental area potentiate amphetamine conditioned place preference, Psychopharmacology, 99, 423, 1989.
188. Hodge, C. W., Haraguchi, M., Erickson, H. L., and Samson, H. H., Microinjections of quinpirole in the ventral tegmentum decrease ethanol reinforced responding, Alcohol. Clin. Exp. Res., 17, 370, 1993.
189. Hodge, C. W., Haraguchi, M., Chappelle, A. M., and Samson, H. H., Effects of ventral tegmental microinjections of the GABAA agonist muscimol on self-administration of ethanol and sucrose, Pharmacol. Biochem. Behav., 53, 971, 1996.
190. Austin, M. C. and Kalivas, P. W., Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum, J. Pharmacol. Exp. Ther., 252, 1370, 1990.
191. Mogenson, G. J. and Nielson, M. A., Evidence that an accumbens to subpallidal GABA-ergic projection contributes to locomotor activity, Brain Res. Bull., 11, 309, 1983.
192. Johnson, P. I., Stellar, J. R., and Paul, A. D., Regional reward differences within the ventral pallidum are revealed by microinjections of a mu opiate receptor agonist, Neuropharmacology, 32, 1305, 1993.
193. McAlonan, G. M., Robbins, T. W., and Everitt, B. J., Effects of medial dorsal thalamic and ventral pallidal lesions on the acquisition of a conditioned place preference: further evidence for the involvement of the ventral striatopallidal system in reward-related processes, Neuroscience, 52, 605, 1993.
194. Hubner, C. B. and Koob, G. F., The ventral pallidum plays a role in mediating cocaine and heroin self-administration in the rat, Brain Res., 508, 20, 1990.
195. Hiroi, N. and White, N. M., The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference, J. Neurosci., 11, 2107, 1991.
196. Deminiere, J. M., Taghzouti, K., Tassin, J. P., Le Moal, M., and Simon, H., Increased sensitivity to amphetamine and facilitation of amphetamine self-administration after 6-hydroxydopamine lesions of the amygdala, Psychopharmacology, 94, 232, 1988.
197. Brown, E. E. and Fibiger, H. C., Differential effects of excitotoxic lesions of the amygdala on cocaine-induced conditioned locomotion and conditioned place preference, Psychopharmacology, 113, 123, 1993.
198. McGregor, A., Baker, G., and Roberts, D. C. S., Effect of 6-hydroxydopamine lesions of the amygdala on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement, Brain Res., 646, 273, 1994.
199. Robledo, P. and Koob, G. F., Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat, Behav. Brain Res., 55, 159, 1993.
200. McGregor, A. and Roberts, D. C. S., Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement, Brain Res., 624, 245, 1993.
201. Loh, E. A., and Roberts, D. C. S., Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin, Psychopharmacology, 101, 262, 1990.
202. Hyytia, P. and Koob, G. F., GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats, Eur. J. Pharmacol., 283, 151, 1995.
203. Corrigall, W. A. and Linseman, M. A., Conditioned place preference produced by intra-hippocampal morphine, Pharmacol. Biochem. Behav., 30, 787, 1988.
204. Stevens, K. E., Shiotsu, G., and Stein, L., Hippocampal μ-receptors mediate opioid reinforcement in the CA3 region, Brain Res., 545, 8, 1991.
205. Cazala, P., Carracq, C., and Saint-Marc, M., Self-administration of morphine into the lateral hypothalamus in the mouse, Brain Res., 416, 283, 1987.
206. David, V. and Cazala, P., Differentiation of intracranial morphine self-administration behavior among five brain regions in mice, Pharmacol. Biochem. Behav., 48, 625, 1994.
207. Olds, M. E., Hypothalamic substrate for the positive reinforcing properties of morphine in the rat, Brain Res., 168, 351, 1979.
208. 2-Met-enkephalinamide at hypothalamic self-stimulation sites, Brain Res., 194, 155, 1980.
209. Agmo, A. and Gomez, M., Conditioned place preference produced by infusion of Met-enkephalin into the medial preoptic area, Brain Res., 550, 343, 1991.
210. Britt, M. D. and Wise, R. A., Opiate rewarding action: independence of the cells of the lateral hypothalamus, Brain Res., 222, 213, 1981.
211. Inglis, W. L. and Winn, P., The pedunculopontine tegmental nucleus: where the striatum meets the reticular formation, Prog. Neurobiol., 47, 1, 1995.
212. Iwamoto, E. T., Nicotine conditions place preferences after intracerebral administration in rats, Psychopharmacology, 100, 251, 1990.
213. Bechara, A. and van der Kooy, D., The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine, J. Neurosci., 9, 3400, 1989.
214. Olmstead, M. C. and Franklin, K. B. J., Lesions of the pedunculopontine tegmental nucleus block drug-induced reinforcement but not amphetamine-induced locomotion, Brain Res., 638, 29, 1994.
215. Olmstead, M. C., Munn, E. M., and Wise, R. A., Effects of pedunculopontine nucleus (PPN) lesions on the acquisition of iv heroin self-administration, Soc. Neurosci. Abstr., 19, 1023, 1993.
216. Olmstead, M. C. and Franklin, K. B. J., Effects of pedunculopontine tegmental nucleus lesions on morphine-induced conditioned place preference and analgesia in the formalin test, Neuroscience, 57, 411, 1993.
217. Gong, W., Neill, D. B., and Justice, J. B., Increased sensitivity to cocaine place-preference conditioning by septal lesions in rats, Brain Res., 683, 221, 1995.
218. Glick, S. D. and Cox, R. D., Changes in morphine self-administration after brainstem lesions in rats, Psychopharmacology, 52, 151, 1977.
219. Kiyatkin, E. A. and Stein, E. A., Biphasic changes in mesolimbic dopamine signal during cocaine self-administration, NeuroReport, 5, 1005, 1994.
220. Kiyatkin, E. A., Wise, R. A., and Gratton, A., Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous heroin self-administration in rats, Synapse, 14, 60, 1993.